These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3073766

  • 1. Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study.
    Caspary L, Creutzig A, Radeke U, Specht S, Alexander K.
    Biomed Biochim Acta; 1988; 47(10-11):S307-10. PubMed ID: 3073766
    [Abstract] [Full Text] [Related]

  • 2. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Alexander K.
    Vasa Suppl; 1988; 23():133-5. PubMed ID: 3061036
    [No Abstract] [Full Text] [Related]

  • 3. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G.
    Wien Klin Wochenschr; 1988 Jul 15; 100(14):484-8. PubMed ID: 3062906
    [Abstract] [Full Text] [Related]

  • 4. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Ranke C, Alexander K.
    Med Klin (Munich); 1988 Jun 17; 83(13-14):434-8. PubMed ID: 3062344
    [No Abstract] [Full Text] [Related]

  • 5. [European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication].
    Laurora G, Corsi M, Bucci M, Cesarone MR, Belcaro G, Dugall M.
    Minerva Cardioangiol; 1998 Oct 17; 46(10 Suppl 1):21-9. PubMed ID: 10658441
    [Abstract] [Full Text] [Related]

  • 6. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul 17; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs].
    Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Christopoulos D, Agus G, Bavera P, Mondani P, Ippolito E, Flenda F.
    Minerva Cardioangiol; 2002 Dec 17; 50(6):683-90. PubMed ID: 12473989
    [Abstract] [Full Text] [Related]

  • 8. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
    Mangiafico RA, Messina R, Attinà T, Dell'Arte S, Giuliano L, Malatino LS.
    Angiology; 2000 Jun 17; 51(6):441-9. PubMed ID: 10870853
    [Abstract] [Full Text] [Related]

  • 9. PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial.
    Belcaro G, Nicolaides AN, Agus G, Cesarone MR, Geroulakos G, Pellegrini L, De Sanctis MT, Incandela L, Ricci A, Mondani P, De Angelis R, Ippolito E, Barsotti A, Vasdekis S, Ledda A, Christopoulos D, Errichi BM, Helmis H, Cornelli U, Ramaswami G, Dugall M, Bucci M, Martines G, Ferrari PG, Corsi M, Di Francescantonio D.
    Angiology; 2000 Aug 17; 51(8 Pt 2):S15-26. PubMed ID: 10959507
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H, Mehlsen J, Petersen JR, Himmelstrup H, Hansen KF.
    Ugeskr Laeger; 1994 Oct 17; 156(42):6207-9. PubMed ID: 7998359
    [Abstract] [Full Text] [Related]

  • 17. Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudication.
    Belch JJ, Bell PR, Creissen D, Dormandy JA, Kester RC, McCollum RD, Mizushima Y, Ruckley CV, Scurr JH, Wolfe JH.
    Circulation; 1997 May 06; 95(9):2298-302. PubMed ID: 9142008
    [Abstract] [Full Text] [Related]

  • 18. [Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication].
    Schräder R, Nachbur B, Mahler F.
    Schweiz Med Wochenschr; 1985 Jun 01; 115(22):752-6. PubMed ID: 3892663
    [Abstract] [Full Text] [Related]

  • 19. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Jun 01; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 20. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 01; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.